1998
DOI: 10.1038/sj.bmt.1701350
|View full text |Cite
|
Sign up to set email alerts
|

A comparative study on the efficacy of CD8-positive cells in enhancing allogeneic bone marrow engraftment: cell sorting vs microbead selection

Abstract: Summary:We have used a superparamagnetic microbead selection system to positively select a murine bone marrow CD8 + cell population. The functional ability of these cells to enhance allogeneic bone marrow engraftment was compared with that of fluorescence activated cell sorter purified CD8 ؉ cells. The CD8 ؉ cell population prepared by the microbead selection procedure was as effective as cell sorter purified CD8 ؉ cells in enhancing T celldepleted allogeneic bone marrow engraftment in lethally irradiated mice… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2005
2005
2005
2005

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 12 publications
(24 reference statements)
0
1
0
Order By: Relevance
“…In a myeloablative murine model of transplantation, both CD4 ϩ and CD8 ϩ cells from the donor can cause GVHD, but donor CD8 ϩ cells were more than 5-fold more effective than CD4 ϩ cells for preventing graft rejection mediated by host immune cells remaining after myleoablation. 20,21 Similarly, other experimental models have shown that donor-derived bone marrow-resident CD8 ϩ cells, but not CD4 ϩ cells, directly facilitate engraftment of purified hematopoietic stem cells. 22,23 In humans, CD4 ϩ cell removal from donor bone marrow does not hinder engraftment, whereas a correlation between graft failure and depletion of donor CD8 ϩ cells has been reported following myeloablative AHCT.…”
Section: Discussionmentioning
confidence: 99%
“…In a myeloablative murine model of transplantation, both CD4 ϩ and CD8 ϩ cells from the donor can cause GVHD, but donor CD8 ϩ cells were more than 5-fold more effective than CD4 ϩ cells for preventing graft rejection mediated by host immune cells remaining after myleoablation. 20,21 Similarly, other experimental models have shown that donor-derived bone marrow-resident CD8 ϩ cells, but not CD4 ϩ cells, directly facilitate engraftment of purified hematopoietic stem cells. 22,23 In humans, CD4 ϩ cell removal from donor bone marrow does not hinder engraftment, whereas a correlation between graft failure and depletion of donor CD8 ϩ cells has been reported following myeloablative AHCT.…”
Section: Discussionmentioning
confidence: 99%